Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine

Clinical trial NCT04930003 · COMPLETED

Trial details

NCT number: NCT04930003
Sponsor: Research Institute for Biological Safety Problems
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Covid19 SARS-CoV Infection Vaccine Adverse Reaction

Start date: 2021-06-15
Primary completion: 2021-12-15
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.